Kidney dysfunction in patients with pulmonary arterial hypertension.
作者： N.P. Nickel , J.M. O’Leary , E.L. Brittain , J.P. Fessel , R.T. Zamanian
DOI: 10.1086/690018
关键词: Decreased cardiac output 、 Renal function 、 Kidney disease 、 Creatinine 、 Medicine 、 Internal medicine 、 Blood pressure 、 Pathophysiology of hypertension 、 Epidemiology 、 Cardiology 、 Disease
摘要: Pulmonary arterial hypertension (PH) and chronic kidney disease (CKD) both profoundly impact patient outcomes, whether as primary disease states or as co-morbid conditions. PH is a …
sagepub.com
uchicago.edu
sci-hub.se 参考文章(198)
Wayne L. Miller, Diane E. Grill, Barry A. Borlaug, Clinical features, hemodynamics, and outcomes of pulmonary hypertension due to chronic heart failure with reduced ejection fraction: pulmonary hypertension and heart failure. Jacc-Heart Failure. ,vol. 1, pp. 290- 299 ,(2013) , 10.1016/J.JCHF.2013.05.001
Effects of an angiotensin-converting -enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients The New England Journal of Medicine. ,vol. 342, pp. 145- 153 ,(2000) , 10.1056/NEJM200001203420301
Malgorzata Jasiewicz, Malgorzata Knapp, Ewa Waszkiewicz, Katarzyna Ptaszynska-Kopczynska, Anna Szpakowicz, Bozena Sobkowicz, Wlodzimierz Jerzy Musial, Karol Adam Kaminski, Enhanced IL-6 trans-signaling in pulmonary arterial hypertension and its potential role in disease-related systemic damage Cytokine. ,vol. 76, pp. 187- 192 ,(2015) , 10.1016/J.CYTO.2015.06.018
Baris Afsar, Alberto Ortiz, Adrian Covic, Abduzhappar Gaipov, Tarik Esen, David Goldsmith, Mehmet Kanbay, Phosphodiesterase type 5 inhibitors and kidney disease. International Urology and Nephrology. ,vol. 47, pp. 1521- 1528 ,(2015) , 10.1007/S11255-015-1071-4
Anju Nohria, Vic Hasselblad, Amanda Stebbins, Daniel F. Pauly, Gregg C. Fonarow, Monica Shah, Clyde W. Yancy, Robert M. Califf, Lynne W. Stevenson, James A. Hill, Cardiorenal Interactions: Insights From the ESCAPE Trial Journal of the American College of Cardiology. ,vol. 51, pp. 1268- 1274 ,(2008) , 10.1016/J.JACC.2007.08.072
Jasper J Brugts, Eric Boersma, Michel Chonchol, Jaap W Deckers, Michel Bertrand, Willem J Remme, Roberto Ferrari, Kim Fox, Maarten L Simoons, Europa Investigators, None, The cardioprotective effects of the angiotensin-converting enzyme inhibitor perindopril in patients with stable coronary artery disease are not modified by mild to moderate renal insufficiency: insights from the EUROPA trial. Journal of the American College of Cardiology. ,vol. 50, pp. 2148- 2155 ,(2007) , 10.1016/J.JACC.2007.08.029
D Castillo-Martínez, E Marroquín-Fabián, A C Lozada-Navarro, M Mora-Ramírez, M Juárez, F Sánchez-Muñoz, J Vargas-Barrón, J Sandoval, L M Amezcua-Guerra, Levels of uric acid may predict the future development of pulmonary hypertension in systemic lupus erythematosus: a seven-year follow-up study. Lupus. ,vol. 25, pp. 61- 66 ,(2016) , 10.1177/0961203315600539
Carl-Henrik Heldin, Serhiy Souchelnytskyi, Aristidis Moustakas, Smad regulation in TGF-beta signal transduction. Journal of Cell Science. ,vol. 114, pp. 4359- 4369 ,(2001) , 10.1242/JCS.114.24.4359
Rozenn Quarck, Tim Nawrot, Bart Meyns, Marion Delcroix, C-reactive protein: a new predictor of adverse outcome in pulmonary arterial hypertension. Journal of the American College of Cardiology. ,vol. 53, pp. 1211- 1218 ,(2009) , 10.1016/J.JACC.2008.12.038
Elaine Soon, Alexi Crosby, Mark Southwood, Peiran Yang, Tamara Tajsic, Mark Toshner, Sarah Appleby, Catherine M Shanahan, Kenneth D Bloch, Joanna Pepke-Zaba, Paul Upton, Nicholas W Morrell, None, Bone morphogenetic protein receptor type II deficiency and increased inflammatory cytokine production. A gateway to pulmonary arterial hypertension. American Journal of Respiratory and Critical Care Medicine. ,vol. 192, pp. 859- 872 ,(2015) , 10.1164/RCCM.201408-1509OC